Rights and permissions
About this article
Cite this article
α-Galactosidase appears to decrease cardiac mass and correct the metabolic defect of Fabry's disease,. Inpharma Wkly. 1292, 6 (2001). https://doi.org/10.2165/00128413-200112920-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200112920-00011